0001562180-21-006756.txt : 20211102 0001562180-21-006756.hdr.sgml : 20211102 20211102163028 ACCESSION NUMBER: 0001562180-21-006756 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Orenstein Daniel H. CENTRAL INDEX KEY: 0001494174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 211371803 MAIL ADDRESS: STREET 1: 311 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-11-01 false 0001636422 Health Catalyst, Inc. HCAT 0001494174 Orenstein Daniel H. C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 false true false false General Counsel Common Stock 2021-11-01 4 M false 2500.00 10.34 A 78046.00 D Common Stock 2021-11-01 4 S false 2359.00 53.5542 D 75687.00 D Common Stock 2021-11-01 4 S false 141.00 54.07 D 75546.00 D Stock Option (Right to Buy) 10.34 2021-11-01 4 M false 2500.00 0.00 D 2026-02-10 Common Stock 2500.00 121000.00 D The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1. Represents the weighted average sale price of the shares sold ranging from $53.05 to $54.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. 25% of the 136,316 shares underlying the options vested in an annual installment on December 31, 2016 and the remaining balance vested in equal monthly installments until the option vested in full on Dec. 31, 2019. /s/ Daniel Orenstein 2021-11-02